Search by Drug Name or NDC

    NDC 00173-0893-14 Trelegy Ellipta 200; 62.5; 25 ug/1; ug/1; ug/1 Details

    Trelegy Ellipta 200; 62.5; 25 ug/1; ug/1; ug/1

    Trelegy Ellipta is a RESPIRATORY (INHALATION) POWDER in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE.

    Product Information

    NDC 00173-0893
    Product ID 0173-0893_d6db0c6b-fa8c-4b68-9ce1-76cac0c042c5
    Associated GPIs 44209903408040
    GCN Sequence Number 081555
    GCN Sequence Number Description fluticasone/umeclidin/vilanter BLST W/DEV 200-62.5 INHALATION
    HIC3 B64
    HIC3 Description BETA-ADRENERGIC-ANTICHOLINERGIC-GLUCOCORT, INHALED
    GCN 48708
    HICL Sequence Number 044508
    HICL Sequence Number Description FLUTICASONE FUROATE/UMECLIDINIUM BROMIDE/VILANTEROL TRIFENAT
    Brand/Generic Brand
    Proprietary Name Trelegy Ellipta
    Proprietary Name Suffix n/a
    Non-Proprietary Name fluticasone furoate, umeclidinium bromide and vilanterol trifenatate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form POWDER
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 200; 62.5; 25
    Active Ingredient Units ug/1; ug/1; ug/1
    Substance Name FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
    Labeler Name GlaxoSmithKline LLC
    Pharmaceutical Class Adrenergic beta2-Agonists [MoA], Anticholinergic [EPC], Cholinergic Antagonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209482
    Listing Certified Through 2024-12-31

    Package

    NDC 00173-0893-14 (00173089314)

    NDC Package Code 0173-0893-14
    Billing NDC 00173089314
    Package 1 TRAY in 1 CARTON (0173-0893-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER
    Marketing Start Date 2020-09-09
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 9.85088
    Pricing Unit EA
    Effective Date 2022-01-01
    NDC Description TRELEGY ELLIPTA 200-62.5-25
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 2, 5
    Classification for Rate Setting B
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis